MSKCC 2024 Update in Hematology and Medical Oncology On Demand

MSKCC 2024 Update in Hematology and Medical Oncology On Demand

Regular price
$130.00
Sale price
$130.00
Regular price
Sold out
Unit price
per 

MSKCC 2024 Update in Hematology and Medical Oncology On Demand (Memorial Sloan Kettering 12th Annual Hematology and Medical Oncology Board Review)

Full Videos + PDF Syllabus Files

By Memorial Sloan Kettering Cancer Center

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

Specialties
Specialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology
Overview

The Memorial Sloan Kettering 12th Annual Hematology and Medical Oncology Board Review is a four day course that provides an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty will focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, central nervous system oncology, and hematologic oncology. Ample time will be provided at the conclusion of each presentation for an interactive question-and-answer session with the speakers.

Target Audience

The target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. This course is designed to enable participants to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.

Objectives
  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
  3. Prepare for ABIM examinations in medical oncology and hematology.

Topics And Speakers:

Friday, March 8, 2024
Relevant Financial Relationships
9:00AM - 9:05AM

View faculty disclosures here.

Colon Cancer
9:15AM - 10:00AM
Leonard B Saltz, MD

Melanoma
10:00AM - 10:45AM
Michael Postow, MD

Prostate Cancer
10:45AM - 11:30AM
Susan Slovin, MD, PhD

Updated as of 3/8/24 at 10:25 am

Kidney Cancer
11:30AM - 12:15PM
Robert Motzer, MD

Mesothelioma
12:15PM - 12:30PM
Marjorie G Zauderer, MD

Urothelial Cancer
1:15PM - 2:00PM
Gopa Iyer, MD

Testis Cancer
2:00PM - 2:45PM
Darren Feldman, MD

Uterine, Cervix, and Other GYN Cancers
2:45PM - 3:30PM
Carol Aghajanian, MD

Ovarian Cancer
3:45PM - 4:30PM
Rachel Grisham, MD

Breast Cancer: Surgery
4:30PM - 5:00PM
Anita Mamtani, MD

Breast Cancer: Radiation Therapy
5:00PM - 5:30PM
Lior Braunstein, MD

Genetics
5:30PM - 6:00PM
Zsofia Stadler, MD
Saturday, March 9, 2024
Small Cell Lung Cancer
7:00AM - 7:30AM
Noura Choudhury, MD, Assistant Attending

Triple Negative Breast Cancer: (Neo)adjuvant and Metastatic
7:30AM - 8:00AM
Rachel Sanford, MD

HER2 Positive Breast Cancer: (Neo)adjuvant and Metastatic
8:00AM - 9:00AM
Chau Dang, MD

Hormone Receptor Positive Breast Cancer: (Neo)adjuvant and Metastatic
9:00AM - 10:00AM
Devika Gajria, MD

Carcinoma of Unknown Primary
10:00AM - 10:45AM
Anna Mary Varghese, MD

Hepatocellular Cancer and Cholangiocarcinoma
10:45AM - 11:30AM
Ghassan K Abou-Alfa, MD, MBA, Professor

Pancreatic and Neuroendocrine Cancer
11:30AM - 12:15PM
Eileen M O'Reilly, MD

Non Small Cell Lung Cancer
1:00PM - 2:00PM
Gregory Riely, MD

Head & Neck, Thyroid, and Non-Melanoma Skin Cancer
2:00PM - 3:00PM
Lara Dunn, MD

Anal and Rectal Cancer
3:00PM - 3:30PM
Michael Foote, MD

Esophageal and Gastric Cancer
3:45PM - 4:30PM
David Ilson, MD, PhD

CNS Tumors
4:30PM - 5:00PM
Thomas Kaley, MD

Sarcoma
5:00PM - 5:30PM
Robert G Maki, MD, PhD, FACP, FASCO

Infectious Disease
5:30PM - 6:00PM
Susan Seo, MD
Sunday, March 10, 2024
Pharmacology
7:00AM - 9:00AM
Mrinal Gounder, MD

Acute Myeloid Leukemia (AML)
9:10AM - 9:50AM
Eytan Stein, MD

Low-Grade Non-Hodgkin Lymphoma (NHL)
9:50AM - 10:30AM
Andrew D Zelenetz, MD, PhD

Chronic Lymphocytic Leukemia (CLL )and Small Lymphocytic Lymphoma (SLL)
10:30AM - 11:10AM
Meghan C Thompson, MD

Updated as of 3/10/24 at 10:15 am

Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Burkitt Lymphoma (BL)
11:10AM - 12:10PM
Paul A Hamlin, MD

Updated as of 3/8/24 at 1:50 pm

Hodgkin Lymphoma (HL) / T Cell
12:40PM - 1:40PM
Alison Moskowitz, MD

Auto/Allo
1:40PM - 2:20PM
Gunjan Shah, MD, MS

CAR T cells
2:20PM - 2:50PM
Michael Scordo, MD

Acute Lymphocytic Leukemia (ALL)
2:50PM - 3:20PM
Jae Park, MD

Myeloproliferative Neoplasms (MPN)
3:40PM - 4:05PM
Raajit Rampal, MD, PhD

Myelodysplastic (MDS)
4:05PM - 4:30PM
Aaron D Goldberg, MD

Chronic Myelogenous Leukemia (CML)
4:30PM - 5:00PM
Michael Mauro, MD

Myeloma / Amyloid
5:00PM - 6:00PM
Malin Hulcrantz, MD
Monday, March 11, 2024
Approach to The Bleeding Patient
8:05AM - 8:50AM
Rekha Parameswaran, MD

The Role of the New Direct Oral Anticoagulants in Practice
8:50AM - 9:50AM
Simon Mantha, MD, MPH

Updated as of 3/11/24 at 7:30 AM

Clotting in Cancer
9:50AM - 10:30AM
Jeffrey Zwicker, MD

Thrombocytopenia, ITP, and Beyond
10:30AM - 11:00AM
Cy R Wilkins, MD

Sickle Cell Disease, Thalassemia
11:00AM - 12:00PM
Susanna Curtis, MD, PhD

 

Sale

Unavailable

Sold Out